Circulating Tumor Cell (CTC) test has been widely adopted for evaluating the prognosis or cure effect of breast cancer. In this test, situations of breast cancer patients are evaluated by counting the number of CTCs in peripheral blood samples. Since conventional method needs fluorescent staining to count CTCs, there are problems of high costs and long process time.

This content is only available via PDF.
You do not currently have access to this content.